Comparative Assessment of Clinically Utilized CD20-Directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK Cell, Monocyte, and Macrophage Properties-Reference-Cited by-同舟云学术

Comparative Assessment of Clinically Utilized CD20-Directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK Cell, Monocyte, and Macrophage Properties

Published:2013-02-15 Issue:6 Volume:190 Page:2702-2711
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Rafiq Sarwish,Butchar Jonathan P.,Cheney Carolyn,Mo Xiaokui,Trotta Rossana,Caligiuri Michael,Jarjoura David,Tridandapani Susheela,Muthusamy Natarajan,Byrd John C.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. The clinical application of monoclonal antibodies in chronic lymphocytic leukemia

2. Rituximab in Chronic Lymphocytic Leukemia

3. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

4. Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia

5. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08

2. Application and Method of Surface Plasmon Resonance Technology in the Preparation and Characterization of Biomedical Nanoparticle Materials;International Journal of Nanomedicine;2024-07

3. NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy;Frontiers in Immunology;2024-06-11

4. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04

5. Anti-CD20 antibody treatment for B-cell malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024